World's Best Scientists 2026 revealed!
Alexander J. Thompson

Alexander J. Thompson

D-Index & Metrics

Biology and Biochemistry

D-Index
74
Citations
35523
World Ranking
5457
National Ranking
2588

Overview

Alexander J. Thompson is affiliated with Ascension Health in the United States and has an extensive research portfolio primarily focused on medical studies related to liver diseases and viral hepatitis. Their work contributes to advancing understanding and treatment options in hepatology and associated fields.

Their research spans several main topics, including:

  • Hepatitis C virus research
  • Hepatitis B virus studies
  • Liver disease diagnosis and treatment
  • Inflammatory bowel disease
  • Liver disease and transplantation
  • Hepatocellular carcinoma treatment and prognosis
  • Hepatitis viruses studies and epidemiology

Alexander J. Thompson's publications appear frequently in several peer-reviewed venues, underlining their focus on hepatology and internal medicine. The key publication venues include:

  • Journal of Hepatology
  • The Medical Journal of Australia
  • Internal Medicine Journal
  • Hepatology International
  • Hepatology Communications

Their recent notable papers include:

  • Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial (2023, The Lancet)
  • APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy (2021, Hepatology International)
  • Standard gastroenterologist versus multidisciplinary treatment for functional gastrointestinal disorders (MANTRA): an open-label, single-centre, randomised controlled trial (2020, The Lancet. Gastroenterology & hepatology)
  • A global investment framework for the elimination of hepatitis B (2020, Journal of Hepatology)
  • Australia needs to increase testing to achieve hepatitis C elimination (2020, The Medical Journal of Australia)

This body of work reflects their main fields of study, with a significant number of publications in:

  • Medicine
  • Epidemiology
  • Hepatology
  • Surgery
  • Genetics
  • Oncology

Alexander J. Thompson collaborates frequently with several researchers, indicating active engagement in multidisciplinary teams. Their frequent co-authors include:

  • Margaret Hellard
  • Joseph Doyle
  • Jessica Howell
  • Jacinta A. Holmes
  • Mark Stoové

Best Publications

  • Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance.

    Dongliang Ge;Jacques Fellay;Alexander J. Thompson;Jason S. Simon

  • Major lipids, apolipoproteins, and risk of vascular disease

    E Di Angelantonio;N Sarwar;P Perry

  • Diabetes mellitus, fasting glucose, and risk of cause-specific death.

    Sreenivasa Rao Kondapally Seshasai;Stephen Kaptoge;Alexander Thompson;Emanuele Di Angelantonio

  • Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

    Sarah Blach;Stefan Zeuzem;Michael Manns;Ibrahim Altraif

  • Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    E. Senkus;S. Kyriakides;F. Penault-Llorca;P. Poortmans

  • Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection

    Graham R. Foster;Nezam Afdhal;Stuart K. Roberts;Norbert Bräu

  • Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus

    Alexander J. Thompson;Andrew J. Muir;Andrew J. Muir;Mark S. Sulkowski;Dongliang Ge

  • Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission

    Graham S Cooke;Isabelle Andrieux-Meyer;Tanya L Applegate;Rifat Atun

  • Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers

    Alexander J.V. Thompson;Tin Nguyen;David Iser;David Iser;Anna Ayres

  • ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C.

    Jacques Fellay;Alexander J. Thompson;Dongliang Ge;Curtis E. Gumbs

  • Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: A perspective on Asia

    Tin Nguyen;Alexander J.V. Thompson;Scott Bowden;Catherine Croagh

  • IL28B genotype is associated with differential expression of intrahepatic interferon‐stimulated genes in patients with chronic hepatitis C

    Thomas J. Urban;Alexander J. Thompson;Shelton S. Bradrick;Jacques Fellay

  • Replicated Association Between an IL28B Gene Variant and a Sustained Response to Pegylated Interferon and Ribavirin

    Jeanette J. McCarthy;Josephine H. Li;Alexander Thompson;Sunil Suchindran

  • Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report.

    Henry Lik-Yuen Chan;Alex Thompson;Michelle Martinot-Peignoux;Teerha Piratvisuth

  • Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein†

    Kumar Visvanathan;Narelle A Skinner;Alex J V Thompson;Stephen M Riordan

  • A Polymorphism Near IL28B Is Associated With Spontaneous Clearance of Acute Hepatitis C Virus and Jaundice

    Hans L. Tillmann;Alex J. Thompson;Keyur Patel;Manfred Wiese

  • An IL28B Polymorphism Determines Treatment Response of Hepatitis C Virus Genotype 2 or 3 Patients Who Do Not Achieve a Rapid Virologic Response

    Alessandra Mangia;Alexander J. Thompson;Rosanna Santoro;Valeria Piazzolla

  • Historical epidemiology of hepatitis C virus (HCV) in selected countries

    P. Bruggmann;T. Berg;A. L. H. Øvrehus;C. Moreno

  • Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines

    Siobhan Dumbreck;Angela Flynn;Moray Nairn;Martin Wilson

  • Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials

    Ira M. Jacobson;Ira M. Jacobson;Eric Lawitz;Edward J. Gane;Bernard E. Willems

Frequent Co-Authors

Margaret Hellard
Margaret Hellard Burnet Institute
Andrew J. Muir
Andrew J. Muir Duke University
Stephen Locarnini
Stephen Locarnini Melbourne Health
Hans L. Tillmann
Hans L. Tillmann East Carolina University
John G. McHutchison
John G. McHutchison Duke University
David Goldstein
David Goldstein University of New South Wales
Gregory J. Dore
Gregory J. Dore University of New South Wales
Michael A. Kamm
Michael A. Kamm University of Melbourne
Mark Stoove
Mark Stoove Burnet Institute
Jacques Fellay
Jacques Fellay École Polytechnique Fédérale de Lausanne

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a degree in Biology or Biochemistry opens multiple doors in healthcare, science, and education. For those interested in human movement and physical health, consider an online exercise physiology degree or an online kinesiology bachelor's degree. Both provide a strong foundation in anatomy, physiology, and the science of physical fitness, leading to roles in sports medicine, rehabilitation, or wellness coaching.

If your interests lean toward advanced clinical practice, there are flexible options to further your credentials. The best online post master's pmhnp programs prepare nurses for specialized roles in psychiatric-mental health, while the 12-month fnp program online offers a streamlined path to becoming a Family Nurse Practitioner.

Each of these online degrees or certificate programs is designed to fit around your schedule, providing both flexibility and specialized knowledge. They can enhance your expertise in areas closely related to Biology and Biochemistry, helping you move forward in the constantly evolving healthcare landscape.

Best Scientists Citing Alexander J. Thompson

Trending Scientists